226 related articles for article (PubMed ID: 8244103)
1. Abnormal plasma polyunsaturated fatty acid pattern in non-active inflammatory bowel disease.
Esteve-Comas M; Núñez MC; Fernández-Bañares F; Abad-Lacruz A; Gil A; Cabré E; González-Huix F; Bertrán X; Gassull MA
Gut; 1993 Oct; 34(10):1370-3. PubMed ID: 8244103
[TBL] [Abstract][Full Text] [Related]
2. Plasma polyunsaturated fatty acid pattern in active inflammatory bowel disease.
Esteve-Comas M; Ramírez M; Fernández-Bañares F; Abad-Lacruz A; Gil A; Cabré E; González-Huix F; Moreno J; Humbert P; Guilera M
Gut; 1992 Oct; 33(10):1365-9. PubMed ID: 1446861
[TBL] [Abstract][Full Text] [Related]
3. Plasma and mucosal fatty acid pattern in colectomized ulcerative colitis patients.
Esteve M; Navarro E; Klaassen J; Abad-Lacruz A; González-Huix F; Cabré E; Ramos E; Condom E; Fernández-Bañares F; Pastor C; Humbert P; Martí-Ragué J; Gassull MA
Dig Dis Sci; 1998 May; 43(5):1071-8. PubMed ID: 9590424
[TBL] [Abstract][Full Text] [Related]
4. Increased catabolism and decreased unsaturation of ganglioside in patients with inflammatory bowel disease.
Miklavcic JJ; Hart TD; Lees GM; Shoemaker GK; Schnabl KL; Larsen BM; Bathe OF; Thomson AB; Mazurak VC; Clandinin MT
World J Gastroenterol; 2015 Sep; 21(35):10080-90. PubMed ID: 26401073
[TBL] [Abstract][Full Text] [Related]
5. Atypical perinuclear antineutrophil cytoplasmic antibodies after colectomy in inflammatory bowel disease.
Freeman HJ; Roeck B; Devine DV; Carter CJ
Can J Gastroenterol; 1997; 11(4):305-10. PubMed ID: 9218855
[TBL] [Abstract][Full Text] [Related]
6. Essential fatty acid depletion in children with inflammatory bowel disease.
Socha P; Ryzko J; Koletzko B; Celinska-Cedro D; Woynarowski M; Czubkowski P; Socha J
Scand J Gastroenterol; 2005 May; 40(5):573-7. PubMed ID: 16036510
[TBL] [Abstract][Full Text] [Related]
7. Determinants of plasma Fatty Acid abnormalities in patients with active inflammatory bowel disease: a multivariate analysis.
Esteve-Comas M; Ramirez M; Fernández-Bañares F; Abad-Lacruz A; Gil A; Cabré E; González-Huix F; Bertrán X; Gassull MA
Inflamm Bowel Dis; 1995; 1(2):95-100. PubMed ID: 23282301
[TBL] [Abstract][Full Text] [Related]
8. Changes in mucosal fatty acid profile in inflammatorybowel disease and in experimental colitis: a common response to bowel inflammation.
Fernández-Bañares F; Esteve-Comas M; Mañé J; Navarro E; Bertrán X; Cabré E; Bartolí R; Boix J; Pastor C; Gassull MA
Clin Nutr; 1997 Aug; 16(4):177-83. PubMed ID: 16844596
[TBL] [Abstract][Full Text] [Related]
9. High circulating concentrations of interleukin-6 in active Crohn's disease but not ulcerative colitis.
Mahida YR; Kurlac L; Gallagher A; Hawkey CJ
Gut; 1991 Dec; 32(12):1531-4. PubMed ID: 1773961
[TBL] [Abstract][Full Text] [Related]
10. High Incidence of Recurrent Crohn's Disease Following Colectomy for Ulcerative Colitis Revealed with Long Follow-Up.
Shamah S; Schneider J; Korelitz BI
Dig Dis Sci; 2018 Feb; 63(2):446-451. PubMed ID: 29282640
[TBL] [Abstract][Full Text] [Related]
11. Biliary lactoferrin concentrations are increased in active inflammatory bowel disease: a factor in the pathogenesis of primary sclerosing cholangitis?
Pereira SP; Rhodes JM; Campbell BJ; Kumar D; Bain IM; Murphy GM; Dowling RH
Clin Sci (Lond); 1998 Nov; 95(5):637-44. PubMed ID: 9791051
[TBL] [Abstract][Full Text] [Related]
12. Occurrence of Crohn's disease in children after total colectomy for ulcerative colitis.
Mortellaro VE; Green J; Islam S; Bass JA; Fike FB; St Peter SD
J Surg Res; 2011 Sep; 170(1):38-40. PubMed ID: 21470637
[TBL] [Abstract][Full Text] [Related]
13. Zinc status in inflammatory bowel disease.
Ainley CC; Cason J; Carlsson LK; Slavin BM; Thompson RP
Clin Sci (Lond); 1988 Sep; 75(3):277-83. PubMed ID: 3416562
[TBL] [Abstract][Full Text] [Related]
14. Plasma transforming growth factor-beta1 level in inflammatory bowel disease.
Kiliç ZM; Ayaz S; Ozin Y; Nadir I; Cakal B; Ulker A
Turk J Gastroenterol; 2009 Sep; 20(3):165-70. PubMed ID: 19821197
[TBL] [Abstract][Full Text] [Related]
15. Smoking influences the need for surgery in patients with the inflammatory bowel diseases: a systematic review and meta-analysis incorporating disease duration.
Kuenzig ME; Lee SM; Eksteen B; Seow CH; Barnabe C; Panaccione R; Kaplan GG
BMC Gastroenterol; 2016 Dec; 16(1):143. PubMed ID: 28003021
[TBL] [Abstract][Full Text] [Related]
16. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
[TBL] [Abstract][Full Text] [Related]
17. Neopterin concentration as an index of disease activity in Crohn's disease and ulcerative colitis.
Husain N; Tokoro K; Popov JM; Naides SJ; Kwasny MJ; Buchman AL
J Clin Gastroenterol; 2013 Mar; 47(3):246-51. PubMed ID: 23269308
[TBL] [Abstract][Full Text] [Related]
18. Plasma viscosity in inflammatory bowel disease.
Lobo AJ; Jones SC; Juby LD; Axon AT
J Clin Pathol; 1992 Jan; 45(1):54-7. PubMed ID: 1740516
[TBL] [Abstract][Full Text] [Related]
19. Mucosal IgG4 cell infiltration in ulcerative colitis is linked to disease activity and primary sclerosing cholangitis.
Raina A; Yadav D; Regueiro M; Krasinskas AM; Saul MI; Sapienza DA; Binion DG; Hartman DJ
Inflamm Bowel Dis; 2013 May; 19(6):1232-7. PubMed ID: 23619716
[TBL] [Abstract][Full Text] [Related]
20. N-3 polyunsaturated fatty acid diet therapy for patients with inflammatory bowel disease.
Uchiyama K; Nakamura M; Odahara S; Koido S; Katahira K; Shiraishi H; Ohkusa T; Fujise K; Tajiri H
Inflamm Bowel Dis; 2010 Oct; 16(10):1696-707. PubMed ID: 20222122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
